Italy· 034494031
ASMAFLU
A flunisolide product containing flunisolide, registered in Italy by DYMALIFE PHARMACEUTICAL S.R.L., on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Flunisolide is registered in 2 of 19 countries.
Countries holding a registration under ATC R03BA03 (flunisolide), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 2 of them publish a price we can compare per daily dose
Flunisolide · ATC R03BA03
2 / 19 countries
- Finlandprice
- Italyprice
The record
At a glance
AIFA (Italy)- Active substance
- Flunisolide
- Manufacturer
- DYMALIFE PHARMACEUTICAL S.R.L.
- Country
- Italy (IT)
- ATC code
- R03BA03
- ATC class
- Flunisolide
- Defined daily dose
- 1 mg, Inhal
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic034494031ADULTI SOLUZIONE DA NEBULIZZARE 15 CONTENITORI MONODOSE DA 2 ML DI SOLUZIONE 2 MG/2 MLEUR 15.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
160 interactions on record for flunisolide.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flunisolide · interactions on record
160 records
- 6 severe
- 40 moderate
- 19 minor
- 95 info
Most severe, free to view
- MifepristoneG03XB01severe
- DesmopressinH01BA02severe
- CladribineL01BB04severe
- Dinutuximab betaL01FX06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flunisolide in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomFlunisolide 25micrograms/dose nasal spraySpecial Order
- United StatesFlunisolideIngenus Pharmaceuticals, LLC
- GermanySyntarisDermapharm Ag
- NorwaySyntarisDermapharm
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Syntaris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b61af0e0-9b20-4af8-8324-1eb02a77a230 GET /v1/drugs/b61af0e0-9b20-4af8-8324-1eb02a77a230?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "ADULTI SOLUZIONE DA NEBULIZZARE 15 CONTENITORI MONODOSE DA 2 ML DI SOLUZIONE 2 MG/2 ML",
"source": "aifa",
"currency": "EUR",
"substance": "Flunisolide",
"reference_pack": "15 UNITA' 2 ML 0,1% - USO RESPIRATORIO",
"public_price_eur": 15.7,
"ssn_reference_price_eur": 15.7
}See everything about flunisolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.